Skip to main content
. 2012 Aug 30;3(9):988–997. doi: 10.18632/oncotarget.634

Figure 1. Treatment with the GHRH antagonist MIA-602 significantly reduces the growth of A.

Figure 1

HCC1806 and B. MX-1 human triple negative breast cancer tumors in nude mice. Animals in the experimental group were treated with subcutaneous administration of 5 μg of MIA-602 daily. Vertical bars indicate ± SEM, n=10 animals, * P < 0.01 vs. control